Nathalie Adda is Sr. VP & Chief Medical Officer of ENANTA PHARMACEUTICALS INC. Currently has a direct ownership of 34,982 shares of ENTA, which is worth approximately $383,052. The most recent transaction as insider was on Apr 04, 2022, when has been sold 32,785 shares (Common Stock) at a price of $72.08 per share, resulting in proceeds of $2,363,143. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35K
0% 3M change
0% 12M change
Total Value Held $383,052

Nathalie Adda Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 04 2022
SELL
Open market or private sale
$2,363,143 $72.08 p/Share
32,785 Reduced 48.38%
34,982 Common Stock
Apr 04 2022
BUY
Exercise of conversion of derivative security
$1,698,591 $51.81 p/Share
32,785 Added 32.61%
67,767 Common Stock
Apr 01 2022
SELL
Open market or private sale
$3,591,711 $71.04 p/Share
50,559 Reduced 59.1%
34,982 Common Stock
Apr 01 2022
BUY
Exercise of conversion of derivative security
$1,852,987 $36.65 p/Share
50,559 Added 37.15%
85,541 Common Stock
Mar 02 2022
SELL
Open market or private sale
$874,544 $70.07 p/Share
12,481 Reduced 26.3%
34,982 Common Stock
Mar 02 2022
BUY
Exercise of conversion of derivative security
$542,424 $43.46 p/Share
12,481 Added 20.82%
47,463 Common Stock
Mar 01 2022
SELL
Open market or private sale
$1,719,794 $70.66 p/Share
24,339 Reduced 41.03%
34,982 Common Stock
Mar 01 2022
BUY
Exercise of conversion of derivative security
$1,057,773 $43.46 p/Share
24,339 Added 29.09%
59,321 Common Stock
Feb 14 2022
SELL
Payment of exercise price or tax liability
$59,615 $62.49 p/Share
954 Reduced 2.65%
34,982 Common Stock
Feb 14 2022
BUY
Grant, award, or other acquisition
-
3,034 Added 7.79%
35,936 Common Stock
Jan 11 2022
SELL
Open market or private sale
$879,150 $70.13 p/Share
12,536 Reduced 27.59%
32,902 Common Stock
Jan 11 2022
BUY
Exercise of conversion of derivative security
$460,447 $36.73 p/Share
12,536 Added 21.62%
45,438 Common Stock
Dec 01 2021
SELL
Payment of exercise price or tax liability
$73,827 $87.68 p/Share
842 Reduced 2.5%
32,902 Common Stock
Dec 01 2021
SELL
Open market or private sale
$1,182,586 $87.45 p/Share
13,523 Reduced 29.13%
32,902 Common Stock
Dec 01 2021
BUY
Exercise of conversion of derivative security
$621,923 $45.99 p/Share
13,523 Added 22.56%
46,425 Common Stock
Nov 19 2021
BUY
Grant, award, or other acquisition
-
6,800 Added 16.77%
33,744 Common Stock
Nov 01 2021
SELL
Open market or private sale
$813,213 $85.18 p/Share
9,547 Reduced 26.16%
26,944 Common Stock
Nov 01 2021
BUY
Exercise of conversion of derivative security
$463,220 $48.52 p/Share
9,547 Added 20.74%
36,491 Common Stock
Oct 11 2021
SELL
Open market or private sale
$284,666 $70.34 p/Share
4,047 Reduced 13.06%
26,944 Common Stock
Oct 11 2021
BUY
Exercise of conversion of derivative security
$175,883 $43.46 p/Share
4,047 Added 11.55%
30,991 Common Stock
Oct 08 2021
SELL
Open market or private sale
$942,921 $70.09 p/Share
13,453 Reduced 33.3%
26,944 Common Stock
Oct 08 2021
BUY
Exercise of conversion of derivative security
$584,667 $43.46 p/Share
13,453 Added 24.98%
40,397 Common Stock
Dec 15 2020
SELL
Payment of exercise price or tax liability
$65,481 $42.52 p/Share
1,540 Reduced 5.41%
26,944 Common Stock
Dec 15 2020
BUY
Exercise of conversion of derivative security
-
5,250 Added 15.56%
28,484 Common Stock
Nov 20 2020
BUY
Grant, award, or other acquisition
-
7,600 Added 24.65%
23,234 Common Stock
NA

Nathalie Adda

Sr. VP & Chief Medical Officer
Watertown, MA

Track Institutional and Insider Activities on ENTA

Follow ENANTA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENTA shares.

Notify only if

Insider Trading

Get notified when an Enanta Pharmaceuticals Inc insider buys or sells ENTA shares.

Notify only if

News

Receive news related to ENANTA PHARMACEUTICALS INC

Track Activities on ENTA